Anastrozole 1 mg/tab 50 pills |

About Anastrozole | HilmaBiocare

Anastrozole - Hilma Biocare

Anastrozole is a prescription aromatase inhibitor (AI) that reduces the conversion of androgens into estrogens by inhibiting the aromatase enzyme. It is widely known under the brand name “Arimidex” and has established medical use, primarily in hormone receptor–positive breast cancer in postmenopausal patients under professional supervision.

General Overview

Class: Aromatase inhibitor (AI), anti-estrogen therapy
Structure: Non-steroidal aromatase inhibitor
Context of use: Prescription medical use under professional supervision; hormone/estrogen management in clinically appropriate cases

Potentially Observed Effects
(based on pharmacological action and clinical use)

Reduction of circulating estradiol levels
Decreased estrogen-related effects in situations where estrogen reduction is clinically indicated
Possible reduction of estrogen-related fluid retention in some individuals (varies by individual)

Safety Information

Anastrozole can be associated with clinically relevant side effects and risks. These may include adverse changes in lipid profile, musculoskeletal discomfort (e.g., joint pain), fatigue, headache, hot flashes, and gastrointestinal symptoms (such as nausea). Longer-term estrogen suppression may negatively affect bone mineral density and increase fracture risk in susceptible individuals. Liver enzyme elevations are possible but not among the most common reactions. Individual responses vary, and use should be guided by a qualified medical professional with appropriate monitoring when indicated.

Disclaimer: This text is provided for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always comply with the laws of your country and use prescription medicines only under qualified medical supervision.